Newsnation
@newsnation·2.7M subscribers·86.7K videos
Ex-FDA commissioner talks why Anktiva is not approved for broader use | CUOMO
Posted
December 2, 2025
Views
88,116
Likes
2,130
Comments
472
Engagement
December 2, 2025
88,116
2,130
472
2.95%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
6:04Now PlayingFormer FDA associate commissioner Peter Pitts joins NewsNation to discuss the overwhelming response to the network’s “Killing Cancer” documentary, which profiled Dr. Patrick SoonShiong and his push to expand access to Anktiva, a drug approved only for a specific type of bladder cancer but showing promise across multiple cancers. Since the special aired, thousands have questioned why they or their loved ones can’t access a treatment they believe could save lives. So why hasn’t the FDA approved Anktiva for broader use? Full Special
Chris Cuomo hosts "CUOMO," a no-nonsense show featuring the day's most important news from all perspectives. "CUOMO" airs weeknights at 8p/7C on NewsNation. #CUOMO
NewsNation is your source for fact-based, unbiased news for all Americans.
More from NewsNation
Get our app
Find us on cable
How to watch on TV or streaming
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
